Logo

ViiV Healthcare Renews its 2015 Collaboration with UNC-Chapel Hill to Discover a Cure for HIV

Share this

ViiV Healthcare Renews its 2015 Collaboration with UNC-Chapel Hill to Discover a Cure for HIV

Shots:

  • ViiV Healthcare has renewed its research agreement with UNC-Chapel Hill to the tune of ~$20M over five years for solely focus on the discovery of therapies for HIV
  • The scientists from both the companies will work at the HIV Cure Center- which was created in 2015 at the start of the collaboration. The public-private collaboration will continue to jointly own Qura Therapeutics- a company managing the IP- commercialization- manufacturing and governance needs of the alliance
  • The partnership is the first-of-its-kind in HIV that brings academic and pharmaceutical research scientists together for developing a new approach to eradicate HIV

Click here ­to­ read full press release/ article | Ref: GSK | Image: Pinterest


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions